COMBINATION OF ANTI-PD-1 ANTIBODIES AND BISPECIFIC ANTI-CD20/ANTI-CD3 ANTIBODIES TO TREAT CANCER

• 收藏
• 分享

专利权人:

发明人:

VARGHESE BINDU,THURSTON GAVIN,LOWY ISRAEL,BROWNSTEIN CARRIE

申请号：

IN201847026441

公开号：

IN201847026441A

申请日:

2018.07.16

申请国别(地区):

IN

年份:

2018

代理人:

摘要：

The present invention provides methods for treating reducing the severity or inhibiting the growth of cancer (e.g. a B-cell cancer such as Hodgkins lymphoma or acute lymphoblastic leukemia). The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of an antibody or antigen-binding fragment thereof that specifically binds to programmed death 1 (PD-1) receptor in combination with a therapeutically effective amount of a bispecific antibody that specifically binds to CD20 and CD3.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/